Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profilingStacey Gargano(Thomas Jefferson University Hospital), Zoran Gatalica(Credo Reference (United States))Cancer MedicineOctober 14, 201910.1002/cam4.2602Cited by 54SaveCiteExport RISWatch citationsRelated PapersA Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors|Clinical Cancer Research|2020|326A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study|Rheumatology and Therapy|2021|34